--

Really interesting. I guess the news isn't widespread because of the points you touched on, primarily that this drug wouldn't benefit the pharmaceutical companies.

--

--

Bebe Nicholson
Bebe Nicholson

Written by Bebe Nicholson

Writer, editor, publisher, journalist, author, columnist, former nonprofit director. bknicholson@att.net

Responses (1)